30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Relay Therapeutics Inc (RLAY)

Track

Over the last 90 days, Relay Therapeutics Inc. has seen significant insider selling, with a net value of approximately -$4.75 million. A total of 11 transactions were recorded, all of which were sales. This activity occurred despite a strong 90-day stock price increase of over 72%. The last earnings report showed a miss of 13.89%.
Stock chart
Ticker: RLAY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Catinazzo Thomas
Chief Financial Officer
4 sales — total 400,000 USD
Planned sale 22 Jun 2026
Value US$954,498.16 | Price 187.58 | Shares 88,816
Planned sale 22 Jun 2026
Value US$3,011,090.00 | Price 235.80 | Shares 83,664
Planned sale 22 Jun 2026
Value US$100,000.00 | Price 16.97 | Shares 1,000
Planned sale 22 Jun 2026
Value US$100,000.00 | Price 17.01 | Shares 1,000
Planned sale 22 Jun 2026
Value US$222,423.70 | Price 486.75 | Shares 82,290
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 15.88 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 15.88 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 15.88 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 15.88 | Shares 1,000
Planned sale 14 May 2026
Value US$227,840.62 | Price 12.86 | Shares 17,717
Proposed sale 14 May 2026
Value US$492,233.48 | Price 13.22 | Shares 37,234
Sale 28 Apr 2026
Value US$22,037.10 | Price 14.79 | Shares 1,490
Sale 28 Apr 2026
Value US$11,136.87 | Price 14.79 | Shares 753
Sale 28 Apr 2026
Value US$14,375.88 | Price 14.79 | Shares 972
Planned sale 9 Apr 2026
Value US$27,000.00 | Price 15.00 | Shares 1,800
Planned sale 7 Apr 2026
Value US$230,498.17 | Price 13.01 | Shares 17,717
Planned sale 9 Mar 2026
Value US$178,233.02 | Price 10.06 | Shares 17,717
Proposed sale 9 Mar 2026
Value US$525,663.39 | Price 9.89 | Shares 53,151
Sale 28 Jan 2026
Value US$22,696.70 | Price 8.45 | Shares 2,686
Sale 28 Jan 2026
Value US$11,441.30 | Price 8.45 | Shares 1,354
Sale 28 Jan 2026
Value US$14,322.75 | Price 8.45 | Shares 1,695
Sale 27 Jan 2026
Value US$143,979.90 | Price 7.62 | Shares 18,895
Sale 27 Jan 2026
Value US$89,032.08 | Price 7.62 | Shares 11,684
Sale 27 Jan 2026
Value US$105,308.40 | Price 7.62 | Shares 13,820
Sale 6 Jan 2026
Value US$337,573.76 | Price 7.82 | Shares 43,168
Sale 3 Nov 2025
Value US$434,511.00 | Price 7.00 | Shares 62,073
Sale 29 Oct 2025
Value US$160,455.00 | Price 7.50 | Shares 21,394
Proposed sale 29 Oct 2025
Value US$160,435.75 | Price 7.50 | Shares 21,394
Sale 28 Oct 2025
Value US$139,494.15 | Price 7.29 | Shares 19,135
Sale 28 Oct 2025
Value US$225,239.13 | Price 7.29 | Shares 30,897
Sale 28 Oct 2025
Value US$157,930.56 | Price 7.29 | Shares 21,664
Sale 9 Jul 2025
Value US$66,541.23 | Price 3.57 | Shares 18,639
Sale 9 Jul 2025
Value US$152,581.80 | Price 3.57 | Shares 42,740
Sale 30 Apr 2025
Value US$82,416.00 | Price 3.00 | Shares 27,472
Sale 30 Apr 2025
Value US$32,217.00 | Price 3.00 | Shares 10,739
Sale 30 Apr 2025
Value US$38,829.00 | Price 3.00 | Shares 12,943
Sale 30 Apr 2025
Value US$38,829.00 | Price 3.00 | Shares 12,943
Planned sale 29 Apr 2025
Value US$11,492.34 | Price 3.23 | Shares 3,558
Proposed sale 29 Apr 2025
Value US$11,492.34 | Price 3.23 | Shares 3,558
Sale 28 Apr 2025
Value US$12,965.30 | Price 3.17 | Shares 4,090
Sale 28 Apr 2025
Value US$4,323.88 | Price 3.17 | Shares 1,364
Sale 28 Apr 2025
Value US$5,211.48 | Price 3.17 | Shares 1,644
Planned sale 28 Apr 2025
Value US$3,109.77 | Price 3.17 | Shares 981
Sale 28 Apr 2025
Value US$5,417.53 | Price 3.17 | Shares 1,709
Proposed sale 28 Apr 2025
Value US$3,109.77 | Price 3.17 | Shares 981
Sale 23 Apr 2025
Value US$55,399.41 | Price 2.97 | Shares 18,653
Sale 23 Apr 2025
Value US$127,023.93 | Price 2.97 | Shares 42,769
Sale 27 Mar 2025
Value US$701.48 | Price 2.84 | Shares 247
Sale 27 Mar 2025
Value US$2,800.24 | Price 2.84 | Shares 986
Planned sale 27 Mar 2025
Value US$12,967.44 | Price 2.84 | Shares 4,566
Sale 27 Mar 2025
Value US$846.32 | Price 2.84 | Shares 298
Sale 27 Mar 2025
Value US$846.32 | Price 2.84 | Shares 298
Proposed sale 27 Mar 2025
Value US$12,967.44 | Price 2.84 | Shares 4,566
Sale 13 Feb 2025
Value US$278,698.80 | Price 3.70 | Shares 75,324
Sale 11 Feb 2025
Value US$539,700.70 | Price 3.85 | Shares 140,182
Sale 30 Jan 2025
Value US$91,896.22 | Price 4.42 | Shares 20,791
Sale 30 Jan 2025
Value US$76,245.00 | Price 4.42 | Shares 17,250
Sale 30 Jan 2025
Value US$91,896.22 | Price 4.42 | Shares 20,791
Sale 30 Jan 2025
Value US$136,237.66 | Price 4.42 | Shares 30,823
Planned sale 29 Jan 2025
Value US$9,595.95 | Price 4.55 | Shares 2,109
Sale 29 Jan 2025
Value US$120,761.55 | Price 4.55 | Shares 26,541
Sale 29 Jan 2025
Value US$211,151.85 | Price 4.55 | Shares 46,407
Proposed sale 29 Jan 2025
Value US$9,595.95 | Price 4.55 | Shares 2,109
Planned sale 28 Jan 2025
Value US$10,570.29 | Price 4.63 | Shares 2,283
Sale 28 Jan 2025
Value US$156,276.39 | Price 4.63 | Shares 33,753
Sale 28 Jan 2025
Value US$7,745.99 | Price 4.63 | Shares 1,673
Sale 28 Jan 2025
Value US$155,975.44 | Price 4.63 | Shares 33,688
Sale 28 Jan 2025
Value US$14,908.60 | Price 4.63 | Shares 3,220
Proposed sale 28 Jan 2025
Value US$10,570.29 | Price 4.63 | Shares 2,283
Proposed sale 23 Jan 2025
Value US$597,162.50 | Price 4.78 | Shares 125,000
Planned sale 23 Jan 2025
Value US$597,500.00 | Price 4.78 | Shares 125,000
Planned sale 22 Jan 2025
Value US$600,000.00 | Price 4.80 | Shares 125,000
Proposed sale 22 Jan 2025
Value US$599,575.00 | Price 4.80 | Shares 125,000
Planned sale 21 Jan 2025
Value US$565,000.00 | Price 4.52 | Shares 125,000
Proposed sale 21 Jan 2025
Value US$565,312.50 | Price 4.52 | Shares 125,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-22 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
88,816 +33.3%
187.58
US$954,498 		88,816 +33.3% 187.58 US$954,498
2026-06-24 2026-06-22 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
83,664 -38.3%
235.80
US$3,011,090 		83,664 -38.3% 235.80 US$3,011,090
2026-06-24 2026-06-22 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
88,563 +30.6%
306.04
US$850,140 		88,563 +30.6% 306.04 US$850,140
2026-06-24 2026-06-22 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
1,000 -9.1%
17.01
US$100,000 		1,000 -9.1% 17.01 US$100,000
2026-06-24 2026-06-22 PlS Planned sale
3.4
Bergstrom Donald A

President, R&D

Officer
1,000 -18.3%
16.94
US$100,000 		1,000 -18.3% 16.94 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.4
DONALD BERGSTROM

Officer

Officer
1,000
15.88
US$100,000 		1,000 15.88 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.4
DONALD BERGSTROM

Officer

Officer
1,000
15.88
US$100,000 		1,000 15.88 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.4
THOMAS CATINAZZO

Officer

Officer
1,000
15.88
US$100,000 		1,000 15.88 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.4
THOMAS CATINAZZO

Officer

Officer
1,000
15.88
US$100,000 		1,000 15.88 US$100,000
2026-05-14 2026-05-14 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -8.3%
12.86
US$227,841 		17,717 -8.3% 12.86 US$227,841
2026-05-14 2026-05-14 PrS Proposed sale
3.4
THOMAS CATINAZZO

Officer

Officer
37,234
13.22
US$492,233 		37,234 13.22 US$492,233
2026-04-30 2026-04-28 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
1,490 -0.4%
14.79
US$22,037 		1,490 -0.4% 14.79 US$22,037
2026-04-30 2026-04-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
753 -0.3%
14.79
US$11,137 		753 -0.3% 14.79 US$11,137
2026-04-30 2026-04-28 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
972 -0.5%
14.79
US$14,376 		972 -0.5% 14.79 US$14,376
2026-04-09 2026-04-09 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
1,800 -0.8%
15.00
US$27,000 		1,800 -0.8% 15.00 US$27,000
2026-04-09 2026-04-07 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -7.7%
13.01
US$230,498 		17,717 -7.7% 13.01 US$230,498
2026-03-11 2026-03-09 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -7.1%
10.06
US$178,233 		17,717 -7.1% 10.06 US$178,233
2026-03-09 2026-03-09 PrS Proposed sale
3.4
THOMAS CATINAZZO

Officer

Officer
53,151
9.89
US$525,663 		53,151 9.89 US$525,663
2026-01-29 2026-01-28 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
2,686 -0.6%
8.45
US$22,697 		2,686 -0.6% 8.45 US$22,697
2026-01-29 2026-01-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
1,354 -0.5%
8.45
US$11,441 		1,354 -0.5% 8.45 US$11,441
2026-01-29 2026-01-28 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
1,695 -0.7%
8.45
US$14,323 		1,695 -0.7% 8.45 US$14,323
2026-01-29 2026-01-27 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
18,895 -4.3%
7.62
US$143,980 		18,895 -4.3% 7.62 US$143,980
2026-01-29 2026-01-27 S Sale
3.2
Rahmer Peter

See remarks

Officer
11,684 -4.0%
7.62
US$89,032 		11,684 -4.0% 7.62 US$89,032
2026-01-29 2026-01-27 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
13,820 -5.2%
7.62
US$105,308 		13,820 -5.2% 7.62 US$105,308
2026-01-07 2026-01-06 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
43,168 -6.1%
7.82
US$337,574 		43,168 -6.1% 7.82 US$337,574
2025-11-04 2025-11-03 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
62,073 -8.1%
7.00
US$434,511 		62,073 -8.1% 7.00 US$434,511
2025-10-30 2025-10-29 S Sale
3.2
Rahmer Peter

See remarks

Officer
21,394 -6.0%
7.50
US$160,455 		21,394 -6.0% 7.50 US$160,455
2025-10-29 2025-10-29 PrS Proposed sale
3.2
Peter J Rahmer

Officer

Officer
21,394
7.50
US$160,436 		21,394 7.50 US$160,436
2025-10-30 2025-10-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
19,135 -5.1%
7.29
US$139,494 		19,135 -5.1% 7.29 US$139,494
2025-10-30 2025-10-28 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
30,897 -5.6%
7.29
US$225,239 		30,897 -5.6% 7.29 US$225,239
2025-10-30 2025-10-28 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
21,664 -6.5%
7.29
US$157,931 		21,664 -6.5% 7.29 US$157,931
2025-07-10 2025-07-09 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
18,639 -2.4%
3.57
US$66,541 		18,639 -2.4% 3.57 US$66,541
2025-07-10 2025-07-09 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
42,740 -5.2%
3.57
US$152,582 		42,740 -5.2% 3.57 US$152,582
2025-04-30 2025-04-30 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
27,472 -4.5%
3.00
US$82,416 		27,472 -4.5% 3.00 US$82,416
2025-04-30 2025-04-30 S Sale
3.2
Rahmer Peter

See remarks

Officer
10,739 -2.7%
3.00
US$32,217 		10,739 -2.7% 3.00 US$32,217
2025-04-30 2025-04-30 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
12,943 -3.2%
3.00
US$38,829 		12,943 -3.2% 3.00 US$38,829
2025-04-30 2025-04-30 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
12,943 -3.5%
3.00
US$38,829 		12,943 -3.5% 3.00 US$38,829
2025-04-30 2025-04-29 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
3,558 -1.0%
3.23
US$11,492 		3,558 -1.0% 3.23 US$11,492
2025-04-29 2025-04-29 PrS Proposed sale
3.4
THOMAS J CATINAZZO

Officer

Officer
3,558
3.23
US$11,492 		3,558 3.23 US$11,492
2025-04-30 2025-04-28 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
4,090 -0.7%
3.17
US$12,965 		4,090 -0.7% 3.17 US$12,965
2025-04-30 2025-04-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
1,364 -0.3%
3.17
US$4,324 		1,364 -0.3% 3.17 US$4,324
2025-04-30 2025-04-28 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
1,644 -0.4%
3.17
US$5,211 		1,644 -0.4% 3.17 US$5,211
2025-04-30 2025-04-28 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
981 -0.3%
3.17
US$3,110 		981 -0.3% 3.17 US$3,110
2025-04-30 2025-04-28 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
1,709 -0.5%
3.17
US$5,418 		1,709 -0.5% 3.17 US$5,418
2025-04-28 2025-04-28 PrS Proposed sale
3.4
THOMAS J CATINAZZO

Officer

Officer
981
3.17
US$3,110 		981 3.17 US$3,110
2025-04-24 2025-04-23 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
18,653 -2.2%
2.97
US$55,399 		18,653 -2.2% 2.97 US$55,399
2025-04-24 2025-04-23 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
42,769 -4.8%
2.97
US$127,024 		42,769 -4.8% 2.97 US$127,024
2025-03-31 2025-03-27 S Sale
3.2
Rahmer Peter

See remarks

Officer
247 -0.1%
2.84
US$701 		247 -0.1% 2.84 US$701
2025-03-31 2025-03-27 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
986 -0.2%
2.84
US$2,800 		986 -0.2% 2.84 US$2,800
2025-03-31 2025-03-27 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
4,566 -1.2%
2.84
US$12,967 		4,566 -1.2% 2.84 US$12,967
2025-03-31 2025-03-27 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
298 -0.1%
2.84
US$846 		298 -0.1% 2.84 US$846
2025-03-31 2025-03-27 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
298 -0.1%
2.84
US$846 		298 -0.1% 2.84 US$846
2025-03-27 2025-03-27 PrS Proposed sale
3.4
THOMAS J CATINAZZO

Officer

Officer
4,566
2.84
US$12,967 		4,566 2.84 US$12,967
2025-02-13 2025-02-13 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
75,324 -7.9%
3.70
US$278,699 		75,324 -7.9% 3.70 US$278,699
2025-02-13 2025-02-11 S Sale
2.6
Patel Sanjiv

President and CEO

Executive Director
140,182 -18.3%
3.85
US$539,701 		140,182 -18.3% 3.85 US$539,701
2025-01-30 2025-01-30 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
20,791 -5.2%
4.42
US$91,896 		20,791 -5.2% 4.42 US$91,896
2025-01-30 2025-01-30 S Sale
3.2
Rahmer Peter

See remarks

Officer
17,250 -4.1%
4.42
US$76,245 		17,250 -4.1% 4.42 US$76,245
2025-01-30 2025-01-30 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
20,791 -4.9%
4.42
US$91,896 		20,791 -4.9% 4.42 US$91,896
2025-01-30 2025-01-30 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
30,823 -4.8%
4.42
US$136,238 		30,823 -4.8% 4.42 US$136,238
2025-01-30 2025-01-29 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
2,109 -0.5%
4.55
US$9,596 		2,109 -0.5% 4.55 US$9,596
2025-01-30 2025-01-29 S Sale
3.2
Rahmer Peter

See remarks

Officer
26,541 -5.9%
4.55
US$120,762 		26,541 -5.9% 4.55 US$120,762
2025-01-30 2025-01-29 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
46,407 -6.7%
4.55
US$211,152 		46,407 -6.7% 4.55 US$211,152
2025-01-29 2025-01-29 PrS Proposed sale
3.4
THOMAS J CATINAZZO

Officer

Officer
2,109
4.55
US$9,596 		2,109 4.55 US$9,596
2025-01-30 2025-01-28 PlS Planned sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
2,283 -0.9%
4.63
US$10,570 		2,283 -0.9% 4.63 US$10,570
2025-01-30 2025-01-28 S Sale
3.4
Catinazzo Thomas

Chief Financial Officer

Officer
33,753 -11.3%
4.63
US$156,276 		33,753 -11.3% 4.63 US$156,276
2025-01-30 2025-01-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
1,673 -0.5%
4.63
US$7,746 		1,673 -0.5% 4.63 US$7,746
2025-01-30 2025-01-28 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
33,688 -10.5%
4.63
US$155,975 		33,688 -10.5% 4.63 US$155,975
2025-01-30 2025-01-28 S Sale
3.4
Bergstrom Donald A

President, R&D

Officer
3,220 -0.6%
4.63
US$14,909 		3,220 -0.6% 4.63 US$14,909
2025-01-28 2025-01-28 PrS Proposed sale
3.4
THOMAS J CATINAZZO

Officer

Officer
2,283
4.63
US$10,570 		2,283 4.63 US$10,570
2025-01-23 2025-01-23 PrS Proposed sale
2.6
THE PATEL FAMILY IRREVOCABLE U/A DTD 11/12/2019

Officer; Director

Executive Director
125,000
4.78
US$597,162 		125,000 4.78 US$597,162
2025-01-23 2025-01-23 PlS Planned sale
2.6
Patel Sanjiv

President and CEO

Executive Director
125,000 -38.5%
4.78
US$597,500 		125,000 -38.5% 4.78 US$597,500
2025-01-23 2025-01-22 PlS Planned sale
2.6
Patel Sanjiv

President and CEO

Executive Director
125,000 -27.8%
4.80
US$600,000 		125,000 -27.8% 4.80 US$600,000
2025-01-22 2025-01-22 PrS Proposed sale
2.6
THE PATEL FAMILY IRREVOCABLE U/A DTD 11/12/2019

Officer; Director

Executive Director
125,000
4.80
US$599,575 		125,000 4.80 US$599,575
2025-01-23 2025-01-21 PlS Planned sale
2.6
Patel Sanjiv

President and CEO

Executive Director
125,000 -21.8%
4.52
US$565,000 		125,000 -21.8% 4.52 US$565,000
2025-01-21 2025-01-21 PrS Proposed sale
2.6
THE PATEL FAMILY IRREVOCABLE U/A DTD 11/12/2019

Officer; Director

Executive Director
125,000
4.52
US$565,312 		125,000 4.52 US$565,312
Explore more

More insider trading research around Relay Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America